In response to the COVID-19 pandemic, we have adapted our work processes to ensure continued delivery of our IP services. Our official meetings have moved to hybrid and virtual modes and we now offer a wide range of webinars with information about our services and IP in general.
We have also developed tools and conducted research to assist scientists, researchers and policymakers in finding solutions to the challenges posed by COVID-19.
Details on how each WIPO service is continuing operations:
We have increased our offerings of virtual meetings and webinars to accommodate for COVID-19 restrictions and them more accessible worldwide.
Delegates can participate remotely and interactively in our formal meetings, thanks to a multi-lingual, cloud-based, virtual conferencing platform.
As part of our COVID-19 response measures, attendees to WIPO meetings should download, print, sign and bring this form 
to WIPO.
We organize free webinars for the latest information and training on WIPO services, databases and program activities.
Our databases provide easy access to crucial information that can help scientists and policymakers develop solutions to COVID-19 challenges.
The glossary contains key concepts related to the COVID-19 pandemic, in the fields of biology, medicine, and public health. It provides easy access to definitions, multilingual equivalents in 10 languages, contexts and concept maps, as well patents containing these terms.
PATENTSCOPE’s COVID-19 Search Facility provides easy access to patent information related to the detection, prevention, and treatment of diseases such as the novel coronavirus.
The WIPO COVID-19 IP Policy Tracker provides information on measures adopted by IP offices in response to the COVID-19 pandemic. The tracker also offers information on legislative and regulatory measures for access and voluntary actions.
Recent WIPO publications cover the impact of the COVID-19 pandemic on innovation.
The Global Innovation Index 2020 (GII) calls on business and policy leaders around the world to sustain innovationin the context of the COVID-19 pandemic.
The second edition of the Trilateral Study on Access to Medical Technologies and Innovation includes a special insert mapping the challenges posed by the COVID-19 pandemic in relation to the integrated health, trade and IP policy frameworks.